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SUMMARY: The size of gastroesophageal varices is one of the most important factors leading to hemorrhage related to portal hypertension. An
endoscopic evaluation of the size of gastroesophageal varices before and after different operations for portal hypertension was performed in 73 patients
with schistosomiasis, as part of a randomized trial: proximal splenorenal shunt (PSS n=24), distal splenorenal shunt (DSS n=24), and esophagogastric
devascularization with splenectomy (EGDS n=25). The endoscopic evaluation was performed before and up to 10 years after the operations. Variceal size
was graded according to Palmer’s classification: grade 1 – up to 3 mm, grade 2 – from 3 to 6 mm, grade 3 – greater than 6 mm, and were analyzed in four
anatomical locations: inferior, middle or superior third of the esophagus, and proximal stomach. The total number of points in the pre-operative grading
minus the number of points in the post-operative grading gave a differential grading, allowing statistical comparison among the surgical groups. Good
results, in terms of disappearance or decrease of variceal size, were observed more frequently after PSS than after DSS or EGDS — 95.8%, 83.3%, and
72%, respectively. When differential grading was analyzed, a statistically significant difference was observed between PSS and EGDS, but not between
proximal and distal splenorenal shunts. In conclusion, shunt surgeries were more efficient than devascularization in diminishing variceal size.
DESCRIPTORS: Hepatosplenic Schistosomiasis. Portal hypertension. Esophageal varices. Surgical treatment. Variceal size.
Nowadays, there are many options
besides surgery for the elective treat-
ment of portal hypertension. Endo-
scopic methods as sclerotherapy1, and
band ligation2, are widely used either
isolated or in different combinations3
whereas N-butyl 2 cyanoacrylate4 can
also be used for obliteration of the va-
rices. Medical therapies comprise dif-
ferent types of drugs such as beta
blockers5 or many others6, and a vas-
cular approach is transjugular porto-
systemic shunting (TIPPS)7. The ulti-
mate goal in any type of treatment for
portal hypertension is the elimination
of the gastroesophageal varices, or at
least reduction of variceal size, since
the presence of gastroesophageal va-
rices is one of the major factors impli-
cated in re-bleeding8.
Surgical treatment aiming at devia-
tion of portal blood to the systemic cir-
culation would be a preferential choice
if severe side effects, such as hepatic
encephalopathy, could be avoided. In
an attempt to maintain good results
without undesirable side effects, tech-
nical modifications have been intro-
duced. The splenorenal shunt was sup-
posed to be as effective as portocaval
shunt, with lower incidence of porto-
systemic encephalopathy; whereas se-
lective decompression of the gastroe-
sophageal venous plexus through a dis-
tal splenorenal shunt could also be an
effective option. Theoretically, devas-
cularization of the gastroesophageal
area tends to maintain a high portal
pressure and therefore a good perfu-
sion to the liver, with the inconvenience
of re-appearance of gastroesophageal
varices, with a higher risk of re-bleed-
ing9.
In a previous paper, we published
the clinical results of a randomized
trial comparing the long-term efficacy
of these three types of surgery10. Al-
though prevalence of re-bleeding was
not statistically different among the
three groups, comparison of the endo-
scopic data has not been performed so
far. In contrast with many studies, the
patients of our earlier trial did not un-
dergo endoscopic or pharmacologic
therapy during the follow-up period.
The purpose of this study was to
evaluate the real contribution of each
type of surgery to alterations in the
status of the varices, particularly re-
garding size.
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PATIENTS AND METHOD
Seventy-three patients with
hepatosplenic schistosomiasis and por-
tal hypertension, randomly assigned to
three types of surgery to prevent re-
bleeding, were evaluated endoscopi-
cally for gastroesophageal status. This
protocol was approved by the Ethical
Committee of the hospital, and a writ-
ten informed consent was obtained
from each patient.
Two shunt procedures namely
proximal splenorenal shunt (PSS) and
distal splenorenal shunt (DSS) were
compared to esophagogastric devascu-
larization with splenectomy (EGDS).
The inclusion criteria for entering the
study were: a) diagnosis of Mansoni
Schistosomiasis based on epidemio-
logical, clinical, and parasitological
data and confirmed by histopathologi-
cal analysis of the wedged liver biopsy
taken at the time of operation; b) age
from 18 to 55 years; c) minimum in-
terval of 15 days between last hemor-
rhage and operation; d) absent or eas-
ily controlled ascites; e) absence of
chronic alcoholism, liver failure, cir-
rhosis, peptic ulcer, diabetes, renal fail-
ure, and portal thrombosis at angiog-
raphy; f) minimum follow-up of 12
months, g) absence of endoscopic,
pharmacologic, or any other kind of
treatment for the portal hypertension
during the whole follow-up period.
Varices, present in all patients be-
fore the operation, were classified ac-
cording to: a) their anatomical location
– inferior, middle or superior part of
esophagus, and proximal stomach and
b) their size — grade 0 = no varices,
grade 1 = varices diameter up to 3 mm,
grade 2 = varices diameter from 3 to 6
mm, and grade 3 = varices diameter
greater than 6 mm11. According to the
protocol, endoscopic evaluation was
performed before the surgical proce-
dure and every one or two years until
5 or 10 years of follow-up. All patients
had a first evaluation one year after sur-
gery, and only 7 of them (9.6%) had
only two endoscopic examinations.
The latest evaluation, usually 5 or 10
years after surgery, was considered for
statistical analysis. The mean period of
time between surgery and the final
evaluation was 5.83 +/-3.05; 6.00 +/-
3.05, and 6.12 +/-2.77 years respec-
tively for PSS, EGDS and DSS.
Under comparative assessment, the
gastroesophageal varices could : I) dis-
appear, II) decrease III) remain un-
changed, or IV) increase during fol-
low-up. The post-operative endoscopic
evaluation was also compared to pre-
operative data by summing up the
grades given to the size of varices —
0 to 3 — in the four different anatomic
sites. The total number of points in the
pre-operative grading (P) minus the to-
tal number of points in the final grad-
ing (E) was used for statistical com-
parisons among the three types of op-
erations. The statistical method applied
was variance analysis with multiple
amplitude comparisons using the test
of Ryan-Einot-Gabriel-Welsch12, and
using SAS (Statistical Analysis Sys-
tem) software.
RESULTS
In Tables 1, 2, and 3 the time of the
latest endoscopic evaluation, total num-
ber of points before (P) and after sur-
gery (E), as well as the difference be-
tween them, is depicted respectively to
PSS, EGDS, and DSS.
When the differential gradings in
the three groups of patients were com-
pared, a statistically significant differ-
ence was obtained. The positive values
for PSS were the highest (3.5 +/-2.9)
and significantly different from EGDS
(1.4 +/-3.3 ). Nevertheless, when DSS
Table 1 – Results of the endoscopic evaluations in the group of patients who
received a proximal splenorenal shunt: time of latest endoscopy, total number of
points in the pre-operative grading, post-operative grading and its difference.
Time of Pre-operative Post-operative
Nº Follow-up Number Number Difference
(years)
1 10 4 0 +4
2 5 6 0 +6
3 10 3 1 +2
4 5 8 4 +4
5 5 2 0 +2
6 10 2 1 +1
7 10 2 0 +2
8 5 2 0 +2
9 1 6 2 +4
10 10 5 2 +3
11 5 9 0 +9
12 1 1 0 +1
13 5 2 0 +2
14 5 4 2 +2
15 10 6 0 +6
16 2 2 1 +1
17 5 12 0 +12
18 5 7 9 -2
19 5 6 4 +2
20 1 7 4 +3
21 5 4 2 +2
22 5 7 1 +6
23 5 5 0 +5
24 10 7 1 +6
Mean 5.83 4.95 1.41 3.54
S.D. 3.05 2.72 2.10 2.91
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is compared either to PSS or EGDS, a
significant difference could not be
found (Table 4).
Good results, in terms of disappear-
ance or decreasing of the variceal size,
were observed more frequently after
PSS than DSS or EGDS (Table 5). In-
creasing of variceal size, on the other
hand, was observed in 20% of the
cases after EGDS and in only 4.2%
(one case ) after the two shunt proce-
dures.
Figure 1 illustrates the pre-opera-
tive and post-operative variceal sizes in
the four anatomic sites. Gastric varices,
present in 33.3%, 20.8%, and 12.0%
before respectively, PSS, DSS, and
EGDS, were present in 0%, 16.6% and
28.0% in the follow-up period.
DISCUSSION
The identification of risk factors for
gastroesophageal bleeding is of utmost
importance, not only for prophylaxis of
the first hemorrhage episode, but also
for patients with risk of re-bleeding.
There is a consensus that bleeding
seems to be high in patients with me-
dium to large varices, although other
endoscopic, hemodynamic, and clini-
cal factors have also been associated
with risk of gastroesophageal bleed-
ing13,14.
More recently, metabolic variables,
such as poor nutritional status, low se-
rum albumin, and decreased clotting
factors were independently associated
with a higher risk of bleeding in cirrho-
sis15. Although interesting, these clini-
cal parameters may be related more to
the hepatic insufficiency of severe cir-
rhosis than to portal hypertension itself.
On the other hand, the endoscopic risk
factors, such as size of varices or red
whale markings would be applicable to
portal hypertension due to other etiolo-
gies besides cirrhosis.
The hepatosplenic form of
Mansoni’s schistosomiasis is an excel-
Table 2 - Results of the endoscopic evaluations in the group of patients who
underwent esophagogastric devascularization with splenectomy: time of latest
endoscopy, total number of points in the pre-operative grading, post-operative
grading and its difference.
Time of Pre-operative Post-operative
Nº Follow-up Number Number Difference
(years)
1 10 3 2 +1
2 5 9 8 +1
3 10 8 7 +1
4 10 4 4 0
5 10 9 2 +7
6 5 1 5 -4
7 5 5 8 -3
8 10 2 4 -2
9 10 5 2 +3
10 10 3 2 +1
11 1 6 1 +5
12 5 5 8 -3
13 3 4 3 +1
14 10 6 2 +4
15 2 6 1 +5
16 5 6 0 +6
17 5 2 0 +2
18 3 4 4 0
19 5 6 12 -6
20 5 4 3 +1
21 5 5 3 +2
22 5 6 5 +1
23 5 5 0 +5
24 5 6 1 +5
25 1 4 3 +1
Mean 6.00 4.96 3.60 1.36
S.D. 3.05 1.98 3.01 3.32
Table 3 - Results of the endoscopic evaluations in the group of patients who received
a distal splenorenal shunt: time of latest endoscopy, total number of points in the
pre-operative grading, post-operative grading and its difference.
Time of Pre-operative Post-operative
Nº Follow-up Number Number Difference
(years)
1 10 8 4 +4
2 5 1 1 0
3 10 5 1 +4
4 10 3 1 +2
5 10 4 2 +2
6 1 4 4 0
7 5 2 1 +1
8 5 2 0 +2
9 5 4 0 +4
10 5 7 0 +7
11 10 5 6 +1
12 5 3 0 +3
13 5 6 2 +4
14 5 2 0 +2
15 5 6 2 +4
16 5 7 2 +5
17 5 6 4 +2
18 1 2 1 +1
19 5 2 2 0
20 10 4 0 +4
21 5 5 1 +4
22 10 3 0 +3
23 5 4 2 +2
24 5 6 1 5
Mean 6.12 4.21 1.54 2.67
S.D. 2.77 1.91 1.58 1.94
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Table 4 - Differential grading of gastroesophageal varices
between pre-operative and post-operative period.
Type of Surgery Mean S. D. Minimum Maximum
PSS 3.5 2.9 -2* 12
EGDS 1.4 3.3  -6* 7
DSS 2.7 1.9  -1* 7
F = 3.86; p = 0.026; S.D. = standard deviatio; * = Negative numbers
correspond to an increase of variceal size when compared to pre-
operative status.
MULTIPLE COMPARISON OF AMPLITUDE
Operations Conclusion
PSS X EGDS *
PSS X DSS N.S.
EGDS X DSS N.S.
* = statistically significant at the level of 5%.
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Figure 1 - Illustration of variceal size in the four anatomic sites.
Table 5 - Comparison of the variations of the size of
gastroesophageal varices before and after different
operations
Type of PSS EGDS DSS TOTAL
Surgery
Varices
Disappear 11 (45.8%) 3 (12%) 7 (29.2%) 21
Decrease 12 (50.0%) 15 (60%) 13 (54.1%) 40
Unchanged 0 2 (8%) 3 (12.5%) 5
Increase 1 (4.2%) 5 (20%) 1 (4.2%) 7
Total 24 25 24 73
PSS = proximal splenorenal shunt.
EGDS = esophagogastric devascularization with splenectomy.
DSS = distal splenorenal shunt.
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lent model for the evaluation of thera-
peutic procedures in portal hyperten-
sion. Upper gastrointestinal hemor-
rhage, occurring as a consequence of
gastroesophageal varices, is the most
outstanding clinical feature, whereas
alterations of liver function are usually
slight, if present at all.9,16 Thus it is pos-
sible to evaluate the consequences of
portal hypertension separately from
those of hepatic insufficiency. This
evaluation is difficult to accomplish in
patients with cirrhosis.
A common and easily reproducible
method for comparing variceal size be-
fore and after a therapeutic procedure
is to evaluate whether varices have dis-
appeared, decreased, remained un-
changed, or increased. The different
percentages obtained in each group, as
shown in Table 5, point to a better per-
formance of PSS and worse results af-
ter EGDS, although these percentages
do not allow statistical comparisons.
A major problem in comparing va-
riceal size to evaluate effectiveness of
a therapeutic procedure is the subjec-
tivity of the procedure. Quantification
of variceal size alterations would be an
ideal approach, if possible. Since a di-
rect measure is not usually performed,
a numerical value (from 0 to 3) was
obtained using a known classification,
in which the terms grade 1, grade 2 and
grade 3 correspond to well known and
accepted criteria of variceal size in mil-
limeters11.
To our knowledge this is the first
time, a statistical analysis has been per-
formed to compare variceal size. It was
interesting to verify that after the three
surgical treatments, a good average re-
sult was achieved in terms of diminish-
ing variceal size. Since we have sub-
tracted from the pre-operative values
those obtained during the follow-up, as
shown in Tables 1, 2, and 3 and in Fig.
1, a positive number is indicative of
smaller varices. On the other hand, in
every type of surgery we also obtained
negative numbers, corresponding to
patients who developed larger varices
during the follow-up.
Presence of gastric varices is a
common finding in portal hyperten-
sion17. In that study, gastric varices
were found in 12 to 33.3% of the cases
in the three groups of patients in the
pre-operative period. When patients
underwent shunt surgeries, a decrease
in size after distal splenorenal shunt
and disappearance after a proximal
splenorenal shunt were observed.
As shown in Fig. 1 the percentage
of gastric varices has increased after
esophagogastric devascularization,
similarly to what may happen after
sclerotherapy, when high levels of por-
tal hypertension persist. Hemodynamic
studies have recently shown that por-
tal pressure can either decrease or in-
crease after sclerotherapy, depending
on presence or absence of spontaneous
collateral circulation in each patient18.
Similarly to what we have observed
in the long-term clinical comparison
among the three types of surgery, it
was not possible to isolate the effects
of DSS from EGDS. On the other hand
EGDS, the surgery with the best results
in terms of survival and lack of side ef-
fects, was the less effective in terms of
improving the gastroesophageal varices
status.
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Um dos mais importantes fatores
que levam à hemorragia digestiva por
hipertensão portal é o calibre das vari-
zes esôfago-gástricas. Visamos, no pre-
sente trabalho, avaliar endoscopi-
camente as variações de calibre antes
e após diferentes cirurgias de hiperten-
são portal, realizadas em 73 pacientes
com esquistossomose hépato-esplê-
nica, no contexto de um estudo contro-
lado e aleatorizado, sendo 24 deles
submetidos a Anastomose Espleno-Re-
nal (AER), 24 a Descompressão Por-
tal Seletiva (DPS) e 25 a Desconexão
Azigo-Portal com Esplenectomia
(DAPE). As avaliações endoscópicas
foram realizadas antes e até 10 anos
após as cirurgias. O calibre das varizes
foi classificado, segundo Palmer como
de grau 1- até 3mm, grau 2 de 3 a 6
mm e grau 3 quando maiores do que
6mm de diâmetro, analizadas em qua-
tro localizações anatômicas a saber:
terços inferior, médio e superior do
esôfago e estômago proximal. A soma-
tória do número de pontos na gradação
pré-operatória menos a somatória dos
pontos na gradação evolutiva forneceu
um número correspondente ao diferen-
cial, que permitiu a comparação esta-
tística entre os diferentes grupos cirúr-
gicos. Na avaliação qualitativa, bons
resultados, correspondendo ao desapa-
recimento ou diminuição do calibre da
varizes, foram encontrados mais fre-
qüentemente após a AER do que DPS
ou DAPE - respectivamente 95,8%,
83,3% e 72%. A análise estatística dos
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diferenciais de gradação demonstrou
diferença estatisticamente significante
favorecendo a AER em relação à
DAPE, não havendo diferenças entre
AER e DPS. Em conclusão, as cirur-
gias de anastomose (“shunt”) foram
mais eficientes do que a desvascula-
rização, em termos de diminuir o cali-
bre de varizes esôfago-gástricas.
DESCRITORES: Esquistossomose
hépato-esplênica. Hipertensão por-
tal. Varizes esofágicas. Tratamento
cirúrgico. Calibre de varizes.
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